To Determine Tolerability to Glucagon Infusion in Obese Subjects
To Determine Tolerability to Glucagon Infusion in Obese Subjects
Active, not recruiting · NCT02817659 · Registry updated 2026-03-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| To Determine Tolerability to Glucagon Infusion in Obese Subjects | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Active, not recruiting | Phase 1 | 2026-03-30 | NCT02817659 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AdventHealth Translational Research Institute | 31 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Translational Research Institute for Metabolism and Diabetes | Orlando | United States | 13 |